Nicholas Investment Partners, LP Q4 2018 Filing

Filed February 14, 2019

Portfolio Value

$930.1M

Holdings

210

Report Date

Q4 2018

Filing Type

13F-HR

All Holdings (210 positions)

#	Stock	Shares	Value	% Portfolio	Type
201	—ARRAY BIOPHARMA INC	930,000	$1.1M	0.12%
202	CLARCLARUS CORP NEW	106,421	$1.1M	0.12%
203	—TEAM INC	1,055,000	$1.0M	0.11%
204	—REPLIGEN CORP	565,000	$959K	0.10%
205	CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC	1,000,000	$700K	0.08%
206	—LIMELIGHT NETWORKS INC	258,279	$604K	0.06%
207	NFLXNETFLIX INC	2,085	$558K	0.06%
208	VRTXVERTEX PHARMACEUTICALS INC	2,725	$452K	0.05%
209	GBTUSDGLOBAL BLOOD THERAPEUTICS IN	9,807	$403K	0.04%
210	ESPRESPERION THERAPEUTICS INC NE	8,353	$384K	0.04%

PreviousPage 3 of 3